Biotech Week Boston highlights research progress in cell and gene therapy

By Samantha Black, PhD, ScienceBoard editor in chief

At Biotech Week Boston, ScienceBoard.net spoke with experts in cell and gene therapy technologies.

Biotech Week Boston is a collection of several industry-leading events, including BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US, and TIDES USA. The event was held at the Boston Convention Center from September 21-23. In attendance were life science professionals with expertise in discovery, financing, manufacturing, and clinical trials.

Video loading ...

We caught up with the following experts:

  • Stefano Menegatti, associate professor at North Carolina State University
  • Armon Sharei, founder and CEO of SQZ Biotech
  • Fabian Gerlinghaus, co-founder and CEO of Cellares
  • Andrew Tustian, director of viral process development at Regeneron Pharmaceuticals

High-throughput analysis speeds downstream process development
Adding high-throughput analysis helped speed up downstream process development for drug candidates based on monoclonal antibodies, according to a case...
Optofluidics aids cell line development for antibody-based therapies
Implementation of optofluidics in cell line development can help advance multiple lead candidate molecules with increased screening capacity. A researcher...

Copyright © 2021 scienceboard.net


Conferences
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter